ATP13A2 novel mutations causing a rare form of juvenile-onset Parkinson disease

Brain Dev. 2018 Oct;40(9):824-826. doi: 10.1016/j.braindev.2018.05.017. Epub 2018 Jun 11.

Abstract

Parkinson disease is a common neurodegenerative disease that typically starts around the age of 60 years; however, juvenile-onset disease can occur rarely. Although Parkinson disease is typically sporadic; in rare occasions, it can be caused by a single gene defect that is inherited in an autosomal dominant, autosomal recessive, or X-linked manner. Herein, we describe a 10-year-old child who had juvenile-onset parkinsonism with rigidity, bradykinesia, dystonia, gait disturbance, and cognitive impairment. Whole exome sequencing showed compound heterozygosity for two previously unreported novel mutations in ATP13A2 (PARK9): a paternally inherited c.1321A>T (p.I441F) and a maternally inherited c.3205G>A (p.A1069T). ATP13A2 mutations are rare cause of autosomal recessive juvenile-onset Parkinson disease. Family co-segregation study and the clinical phenotype support that p.I441F and p.A1069T are indeed disease-causing mutations.

Keywords: ATP13A2; Juvenile-onset Parkinson; Novel mutations; Whole exome sequencing.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Humans
  • Male
  • Mutation*
  • Parkinsonian Disorders / diagnostic imaging
  • Parkinsonian Disorders / genetics*
  • Parkinsonian Disorders / physiopathology
  • Pedigree
  • Phenotype
  • Proton-Translocating ATPases / genetics*

Substances

  • ATP13A2 protein, human
  • Proton-Translocating ATPases